147 related articles for article (PubMed ID: 23368889)
1. In vitro interaction of artemisinin derivatives or the fully synthetic peroxidic anti-malarial OZ277 with thapsigargin in Plasmodium falciparum strains.
Abiodun OO; Brun R; Wittlin S
Malar J; 2013 Jan; 12():43. PubMed ID: 23368889
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277).
Uhlemann AC; Wittlin S; Matile H; Bustamante LY; Krishna S
Antimicrob Agents Chemother; 2007 Feb; 51(2):667-72. PubMed ID: 17145800
[TBL] [Abstract][Full Text] [Related]
3. Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals.
Fügi MA; Wittlin S; Dong Y; Vennerstrom JL
Antimicrob Agents Chemother; 2010 Mar; 54(3):1042-6. PubMed ID: 20028825
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.
Lanteri CA; Chaorattanakawee S; Lon C; Saunders DL; Rutvisuttinunt W; Yingyuen K; Bathurst I; Ding XC; Tyner SD
Antimicrob Agents Chemother; 2014 Oct; 58(10):5831-40. PubMed ID: 25049252
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Snyder C; Chollet J; Santo-Tomas J; Scheurer C; Wittlin S
Exp Parasitol; 2007 Mar; 115(3):296-300. PubMed ID: 17087929
[TBL] [Abstract][Full Text] [Related]
6. Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
Kaiser M; Wittlin S; Nehrbass-Stuedli A; Dong Y; Wang X; Hemphill A; Matile H; Brun R; Vennerstrom JL
Antimicrob Agents Chemother; 2007 Aug; 51(8):2991-3. PubMed ID: 17562801
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate.
Baumgärtner F; Jourdan J; Scheurer C; Blasco B; Campo B; Mäser P; Wittlin S
Malar J; 2017 Jan; 16(1):45. PubMed ID: 28122617
[TBL] [Abstract][Full Text] [Related]
8. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
Marfurt J; Chalfein F; Prayoga P; Wabiser F; Wirjanata G; Sebayang B; Piera KA; Wittlin S; Haynes RK; Möhrle JJ; Anstey NM; Kenangalem E; Price RN
Antimicrob Agents Chemother; 2012 Oct; 56(10):5258-63. PubMed ID: 22850522
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.
Kocken CH; van der Wel A; Arbe-Barnes S; Brun R; Matile H; Scheurer C; Wittlin S; Thomas AW
Exp Parasitol; 2006 Jul; 113(3):197-200. PubMed ID: 16458301
[TBL] [Abstract][Full Text] [Related]
10. Antimalarial activity of a synthetic endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum isolates from Gabon.
Kreidenweiss A; Mordmüller B; Krishna S; Kremsner PG
Antimicrob Agents Chemother; 2006 Apr; 50(4):1535-7. PubMed ID: 16569877
[TBL] [Abstract][Full Text] [Related]
11. System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion.
Giannangelo C; Siddiqui G; De Paoli A; Anderson BM; Edgington-Mitchell LE; Charman SA; Creek DJ
PLoS Pathog; 2020 Jun; 16(6):e1008485. PubMed ID: 32589689
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of P. falciparum populations from Colombia and Tanzania to a new synthetic peroxide (OZ277).
Osorio L; Murillo C; Aponte S; Mayagaya V; Scheurer C; Brun R; Matile H; Wittlin S
Am J Trop Med Hyg; 2007 Jun; 76(6):1024-6. PubMed ID: 17556605
[TBL] [Abstract][Full Text] [Related]
13. Identification of an antimalarial synthetic trioxolane drug development candidate.
Vennerstrom JL; Arbe-Barnes S; Brun R; Charman SA; Chiu FC; Chollet J; Dong Y; Dorn A; Hunziker D; Matile H; McIntosh K; Padmanilayam M; Santo Tomas J; Scheurer C; Scorneaux B; Tang Y; Urwyler H; Wittlin S; Charman WN
Nature; 2004 Aug; 430(7002):900-4. PubMed ID: 15318224
[TBL] [Abstract][Full Text] [Related]
14. In vitro assessment of the pharmacodynamic properties of DB75, piperaquine, OZ277 and OZ401 in cultures of Plasmodium falciparum.
Hofer S; Brun R; Maerki S; Matile H; Scheurer C; Wittlin S
J Antimicrob Chemother; 2008 Nov; 62(5):1061-4. PubMed ID: 18669520
[TBL] [Abstract][Full Text] [Related]
15. Parasite-Mediated Degradation of Synthetic Ozonide Antimalarials Impacts
Giannangelo C; Stingelin L; Yang T; Tilley L; Charman SA; Creek DJ
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263074
[TBL] [Abstract][Full Text] [Related]
16. The structure-activity relationship of the antimalarial ozonide arterolane (OZ277).
Dong Y; Wittlin S; Sriraghavan K; Chollet J; Charman SA; Charman WN; Scheurer C; Urwyler H; Santo Tomas J; Snyder C; Creek DJ; Morizzi J; Koltun M; Matile H; Wang X; Padmanilayam M; Tang Y; Dorn A; Brun R; Vennerstrom JL
J Med Chem; 2010 Jan; 53(1):481-91. PubMed ID: 19924861
[TBL] [Abstract][Full Text] [Related]
17. In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum.
Maerki S; Brun R; Charman SA; Dorn A; Matile H; Wittlin S
J Antimicrob Chemother; 2006 Jul; 58(1):52-8. PubMed ID: 16735432
[TBL] [Abstract][Full Text] [Related]
18. Endoperoxide Drug Cross-Resistance Patterns for Plasmodium falciparum Exhibiting an Artemisinin Delayed-Clearance Phenotype.
Siriwardana A; Iyengar K; Roepe PD
Antimicrob Agents Chemother; 2016 Nov; 60(11):6952-6956. PubMed ID: 27600038
[TBL] [Abstract][Full Text] [Related]
19. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
20.
Straimer J; Gnädig NF; Stokes BH; Ehrenberger M; Crane AA; Fidock DA
mBio; 2017 Apr; 8(2):. PubMed ID: 28400526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
